Across TCGA pan-cancer cohorts, RNU2-29P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU2-29P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RNU2-29P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU2-29P is over-expressed in tumor.

BRCA, LUAD, and LUSC are the cancer types where RNU2-29P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU2-29P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	+0.042	.007	4	view →
LUAD	Male	All	+0.213	.011	2	view →
LUSC	Male	All	+0.113	.038	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU2-29P RNA expression & survival · all RNU2-29P data types